Characteristics of participants in a fully decentralized dermatologic clinical trial evaluating the safety and efficacy of topical ruxolitinib monotherapy for atopic dermatitis (Preprint)

<sec> <title>UNSTRUCTURED</title> A decentralized dermatological clinical trial model can be used to improve participation for populations underrepresented in clinical research. </sec>

Authors

Jonathan Cotliar
Robert R. Stavert (ORCID: https://orcid.org/0000-0002-2253-7998)
Katherine Mangialardi

Publication Details

Published: 2025-09-04
DOI: https://doi.org/10.2196/preprints.83554
Primary Topic: Dermatology and Skin Diseases
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Characteristics of participants in a fully decentralized dermatologic clinical trial evaluating the safety and efficacy of topical ruxolitinib monotherapy for atopic dermatitis (Preprint)

Jonathan Cotliar, Robert R. Stavert, Katherine Mangialardi

Sep 4, 2025

Dermatology and Skin Diseases

article

Characteristics of participants in a fully decentralized dermatologic clinical trial evaluating the safety and efficacy of topical ruxolitinib monotherapy for atopic dermatitis (Preprint)

Jonathan Cotliar, Robert R. Stavert, Katherine Mangialardi

September 4, 2025article en

Abstract

<sec> <title>UNSTRUCTURED</title> A decentralized dermatological clinical trial model can be used to improve participation for populations underrepresented in clinical research. </sec>

Openalex Percentile: Top 56%

Dermatology and Skin Diseases

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Characteristics of participants in a fully decentralized dermatologic clinical trial evaluating the safety and efficacy of topical ruxolitinib monotherapy for atopic dermatitis (Preprint) — Jonathan Cotliar, Robert R. Stavert, et al. · (2025) | TGRS Research Map | TGRS